Literature DB >> 11784627

Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.

T Kühne1, P Imbach, P H Bolton-Maggs, W Berchtold, V Blanchette, G R Buchanan.   

Abstract

BACKGROUND: Diagnosis and management of idiopathic thrombocytopenic purpura (ITP) have been based primarily on expert opinion and practice guidelines rather than on evidence. We have used a registry to prospectively survey the presenting features and the diagnostic evaluation and management practices used for children with ITP worldwide.
METHODS: We used the Intercontinental Childhood ITP Registry which had been widely advertised. 209 physicians from 136 institutions in 38 countries participated by submitting data for each of their newly diagnosed patients. Data from 2031 children with ITP was registered between June, 1997, and May, 2000, and we analysed 6-month follow-up data from 1496 children.
FINDINGS: There was a peak in occurrence of childhood ITP during spring and a nadir in the autumn. Mean initial platelet count was 15.4x10(9)/L (SD 19.7). 1447 (73%) of 1976 children were admitted to hospital. Initial management consisted of no drug treatment in 612 (31%), intravenous immunoglobulin in 576 (29%), corticosteroids in 651 (33%), or both in 137 (7%) patients. Intracranial haemorrhage was reported in two patients.
INTERPRETATION: The variable approaches to management of childhood ITP demonstrate the need for prospective clinical trials, which should be feasible within such a study group.

Entities:  

Mesh:

Year:  2001        PMID: 11784627     DOI: 10.1016/S0140-6736(01)07219-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  Seasonal variation of immune thrombocytopenic purpura related hospitalizations among adults in the USA: analysis of the nationwide inpatient sample database.

Authors:  Smith Giri; Ranjan Pathak; Madan R Aryal; Paras Karmacharya; Vijaya R Bhatt; Mike G Martin
Journal:  Ther Adv Hematol       Date:  2015-08

2.  Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?

Authors:  Iris Treutiger; Jukka Rajantie; Bernward Zeller; Jan-Inge Henter; Göran Elinder; Steen Rosthøj
Journal:  Arch Dis Child       Date:  2007-04-25       Impact factor: 3.791

3.  Acute immune thrombocytopenic purpura: What do we do when things go well?

Authors:  Robert Klaassen
Journal:  Paediatr Child Health       Date:  2002-07       Impact factor: 2.253

4.  Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Authors:  Thomas Kühne; Willi Berchtold; Lisa A Michaels; Runhui Wu; Hugo Donato; Bibiana Espina; Hannah Tamary; Francesco Rodeghiero; Meera Chitlur; Johannes Rischewski; Paul Imbach
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

Review 5.  Pediatric ITP: is it different from adult ITP?

Authors:  Jenny M Despotovic; Amanda B Grimes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

6.  Newly diagnosed immune thrombocytopenia: update on diagnosis and management.

Authors:  Deepak Bansal; Aruna Rajendran; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2013-10-05       Impact factor: 1.967

7.  Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Authors:  Federica Bertuola; Carla Morando; Francesca Menniti-Ippolito; Roberto Da Cas; Annalisa Capuano; Giorgio Perilongo; Liviana Da Dalt
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

8.  Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP Centres: do we overtreat? Data from a multicentre, prospective cohort study.

Authors:  Emilia Parodi; Giovanna Russo; Piero Farruggia; Lucia D Notarangelo; Maria T Giraudo; Margherita Nardi; Fiorina Giona; Paola Giordano; Ugo Ramenghi; Angelica Barone; Gianluca Boscarol; Simone Cesaro; Francesca Fioredda; Saverio Ladogana; Maria Licciardello; Francesca Rossi; Laura Rubert; Marco Spinelli; Fabio Tucci
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

9.  B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.

Authors:  Paola Giordano; Simona Cascioli; Giuseppe Lassandro; Valentina Marcellini; Fabio Cardinale; Federica Valente; Franco Locatelli; Rita Carsetti
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

Review 10.  Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.

Authors:  Paul Imbach
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.